VOLUNTEER FOR RESEARCH

tincture icon.png

Hemp-Derived Cannabidiol (CBD) for Anxiety

This project is an FDA-approved clinical trial of a hemp-derived, high-CBD sublingual product for the treatment of anxiety.

BAcKGROUND

Clinical Trial

STUDY DETAILS

Participants are assessed at 7 visits over the course of 6 weeks.

The primary outcome measures of the study are clinical state measures related to anxiety. Additionally, participants will complete measures related to quality of life, sleep, and activity levels, and cognitive testing.


RECRUITMENT INFORMATION

Individuals with moderate to severe anxiety who are interested in using a hemp-derived high CBD product may be eligible.

We are currently recruiting individuals for the open-label phase (all participants would receive active treatment).